MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Open-Label, Single-Arm, Exploratory Trial of Opicapone: Status Update of the OASIS (OPICAPONE IN SLEEP DISORDER) Study

    R. Costa, J. Ferreira, D. Magalhães, J-F. Rocha, P. Soares-da-Silva (Coronado, Portugal)

    Objective: This study aims to evaluate the effects of opicapone (OPC) 50 mg treatment on sleep disorders in patients with Parkinson’s disease (PD) and ‘wearing-off’.…
  • 2022 International Congress

    The use of artificial intelligence-based chatbot in Parkinson’s disease

    G. Oyama, M. Ogawa, K. Morito, M. Kobayashi, Y. Yamada, K. Shinkawa, H. Kamo, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: This study aimed to assess the feasibility and efficacy of using an artificial intelligence-based chatbot for smile and speech in Parkinson’s disease (PD). Further,…
  • 2022 International Congress

    The role of GBA1 mutations in the relationship between GBA1 and alpha-synuclein in Parkinson disease

    L. Smith, M. Gegg, D. Chau, AHV. Schapira (London, United Kingdom)

    Objective: The aim of the study was to understand how the E326K GBA1 mutation results in an increased risk for Parkinson disease, through influencing the…
  • 2022 International Congress

    The STEPWISE Parkinson study: a Smartphone Based Exercise Solution for Patients With Parkinson’s Disease

    S. Schootemeijer, N. de Vries, E. Macklin, A. Ascherio, M. Schwarzschild, B. Bloem (Nijmegen, Netherlands)

    Objective: To investigate the feasibility of a smartphone app (STEPWISE app) to increase the physical activity level (i.e. number of steps) in people with Parkinson’s…
  • 2022 International Congress

    Understanding patient perceptions of the key components of Medication Adherence in PD: a multicenter, international study

    M. Tosin, C. Goetz, D. Hall, G. Stebbins, B. Oliveira (Chicago, USA)

    Objective: To understand how patients with Parkinson's disease (PD) and their care partners describe medication adherence. Background: Medication adherence in is a complex construct, associated…
  • 2022 International Congress

    The Complexity of Parkinson Disease Medication Regimens May Factor into Treatment Decisions: Results of a PMD Alliance Survey

    J. Farmer, C. Goas, J. Rivera, A. Mitchell, A. Merriam, N. Crouse, A. Formella (Pennington, USA)

    Objective: Identify factors affecting PwPD and CP communications with HCPs regarding dyskinesia and OFF episodes. Background: Managing Parkinson Disease (PD) requires clear and open communication…
  • 2022 International Congress

    Environmental factors and Parkinson’s disease

    Y. Babajani, M. Salari, M. Afroozian, M. Etemadifar (Tehran, Islamic Republic of Iran)

    Objective: To assess environmental factors in the development and protection of Parkinson's disease. Background: The cause of Parkinson's disease is not known, but in summarizing…
  • 2022 International Congress

    Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: TALISMAN study rationale and protocol

    J. Janssen Daalen, M. Meinders, B. Stunnenberg, H. Groenewoud, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)

    Objective: This is the first study that will assess the potential impact of hypoxia-based therapy in individuals with PD on respiratory parameters and PD symptoms.…
  • 2022 International Congress

    Local Field Potential Recordings in Parkinson’s Disease at Home: A Case Series Report

    K. Martinez, V. Madrigal, N. Morelli, A. Singer (Aliso Viejo, USA)

    Objective: To report novel, real-world use of chronic local field potential (LFP) sensing in patients with Parkinson’s disease (PD) outside-of-clinic settings. Background: Recent advancements in…
  • 2022 International Congress

    The impact of COVID-19 on Parkinson’s disease: a case-controlled registry and questionnaire study

    G. Cedergren Weber, P. Odin, J. Timpka (Lund, Sweden)

    Objective: The purpose of the study was to explore how having suffered through COVID-19 affects motor, nonmotor and general health aspects of Parkinson’s disease, and…
  • « Previous Page
  • 1
  • …
  • 226
  • 227
  • 228
  • 229
  • 230
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley